Jacobio Pharmaceuticals Group Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 40.34 million compared to CNY 54.69 million a year ago. Net loss was CNY 166.28 million compared to CNY 127.83 million a year ago.

Basic loss per share from continuing operations was CNY 0.22 compared to CNY 0.17 a year ago.